Trident Texofab reports FY26 profit of ₹70.46 lakh

Trident Texofab Limited reported a net profit of ₹70.46 lakh for the financial year ended March 31, 2026, a decline from ₹251.01 lakh in the previous year. The company recorded a net loss of ₹200.94 lakh for the quarter ended March 31, 2026, compared to a net profit of ₹51.05 lakh in the same period last year. Revenue from operations for the year stood at ₹11,986.35 lakh, while total income for the quarter was ₹3,410.25 lakh.

Financial Performance Overview

The Board of Directors approved the audited standalone financial results on May 30, 2026. The statutory auditors issued an audit report with an unmodified opinion on the financial results. The company disclosed that the trading window for designated persons remains closed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, and will reopen 48 hours after the financial results are made public.

Key Financial Metrics

Equity share capital rose to ₹1,499.58 lakh from ₹1,355.88 lakh in FY25. The earnings per share (EPS) for the year was ₹0.54 on a basic and diluted basis, compared to ₹2.38 and ₹2.09 respectively in the previous year. For the quarter ended March 31, 2026, the EPS was (₹1.30) on a basic and diluted basis.

Metric	FY26 (₹ in Lakhs)	FY25 (₹ in Lakhs)
Total Income from Operations	11,986.35	12,535.75
Net Profit for the Period	70.46	251.01
Equity Share Capital	1,499.58	1,355.88
Total Comprehensive Income	79.93	245.06

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-4.98%	-4.59%	-12.66%	-85.36%	-82.72%	-3.49%

Trident Texofab Limited has issued a formal response to BSE Limited regarding inquiries about significant movement in its share price, clarifying that no undisclosed material information is affecting the stock's performance.

Company's Official Response to BSE

In a communication dated April 16, 2026, Trident Texofab addressed BSE's letter dated April 15, 2026, which sought clarification on the notable price movement of the company's shares. The response was signed by Rahul Jariwala, Company Secretary and Compliance Officer.

Parameter	Details
Communication Date	April 16, 2026
BSE Reference	Letter No. L/SURV/ONL/PV/APJ/2026-2027/3730
Stock ID	TTFL
Scrip Code	540726

Regulatory Compliance and Disclosure Status

The company emphasized its commitment to regulatory compliance, stating that all material information and announcements that may impact operations or performance have been consistently disclosed. Trident Texofab confirmed adherence to the following regulatory frameworks:

Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Insider trading regulations
Timely disclosure requirements within stipulated timeframes

Market-Driven Price Movement

Triden Texofab categorically stated that the recent share price movement is purely attributable to market conditions and market-driven factors. The company clarified that it neither has control over such price movements nor possesses knowledge of the specific reasons behind the volatility.

The textile manufacturer confirmed that there is no pending information or announcement that could have a bearing on the company's share price movement, reinforcing transparency in its communication with stakeholders.

Corporate Communication Details

The official response was digitally signed by Rahul Jariwala, Company Secretary and Compliance Officer (Membership No: A70164), on April 16, 2026, at 16:47:14 +05'30'. This formal communication ensures proper documentation and regulatory compliance in addressing BSE's inquiry about the share price movement.